Slightly tangential to CJC-1295/Ipamorelin but pam_columbus reminded me — what is the latest on the oral formulations?
I know it is not exactly on-topic but it seems related enough to ask here rather than starting a new thread. Apologies if this has been covered — I did search first.
Thanks for sharing this, pam_columbus. A few questions about your CJC-1295/Ipamorelin experience:
- What dose worked best for you?
- How long before you noticed appetite suppression kicking in?
- Did your endo have any specific recommendations about CJC-1295/Ipamor?
I am in a similar boat and trying to learn from others' experiences before my next appointment.
Sigma-Aldrich — Research-Grade Standards
Certified reference materials, analytical reagents, and research-grade standards for peptide verification. Trusted by laboratories worldwide.
Shop Reference StandardsOP here — wow, did not expect this much response! Thank you all for the thoughtful replies on CJC-1295/Ipamorelin.
To answer mike_mealprep: yes, I am on compounded sema from a 503B pharmacy.
Quick update: things are still going well. Thanks again for the evidence-based discussion — this is exactly why I posted in a science-based community. 🙏
Relevant to CJC-1295/Ipamorelin — here is my latest bloodwork comparison:
Key improvements: A1C 7.6% → 5.5%, triglycerides 197 → 97 mg/dL, hsCRP 8.0 → 0.9 mg/L. All on tirzepatide for 13 months.
The inflammatory marker drop is what impresses me most. Consistent with the SELECT trial's cardiovascular findings.